figshare
Browse
Fig_4.tif (1.7 MB)

The model accurately reproduces activation of inflammatory and anti-apoptotic signals, controlled through IL-1RI and TILRR.

Download (0 kB)
figure
posted on 2015-06-25, 03:37 authored by David M. Rhodes, Sarah A. Smith, Mike Holcombe, Eva E. Qwarnstrom

A. TILRR siRNA decreases IκBα degradation in HeLa cells transfected with IκBα-EGFP (7μg/106 cells) alone or in the presence of random (♦) or TILRR-specific (■) siRNA and stimulated with IL-1 (1 nM). Graph show continuous readings from three experiments including 55 cells, p<0.05 at 60 min. B. Simulations using the best-fit model, show reductions in transfected IκBα-EGFP degradation during IL-1β stimulation in the presence (Red) and absence (Blue) of TILRR, and are in agreement with published data (A). C, D. TILRR cDNA increases (C) and TILRR siRNA decreases (D) IL-8 luciferase activity in HeLa cells treated with IL-1β (1nM, 6 hrs.) (Mean±SEM, n = 3, *p <0.05; **p< 0.01). E, F. Simulations of un-stimulated levels (black) and IL-1β-induced IL-8 activity (blue) in the presence of the IL-1RI complex and with increasing (E) and decreasing (F) TILRR expression relative to endogenous levels, using the agent-based model, show agreement with in vitro data in C and D. (Mean±SEM, n = 3, 0.005In vitro experiments (G) (Mean± SEM, n = 3, * p <0.005) and model simulation (H) (Mean ± SEM, n = 3, WT vs. D448 p<0.0.001). I, J. Mutation of residue D448 results in a 60% reduction in inflammatory gene activity, while other mutants have no impact (I) (arrows indicate WT TILRR and the R425 and D448 mutants, Mean±SEM, n = 3, * p<0.001). Model simulations (J) similarly show a pronounced reduction in the presence of the D448 mutant, but no effect by substitution of R425. (Mean±SEM, n = 3, WT vs. D448 p<0.001). K, L. TILRR-induced increase in levels of phosphor-Akt by IL-1β (1nM) is blocked following mutation of residue R425, while substitution at D448 has the same effect as the wild type co-receptor. In vitro experiments (K) (Data are expressed relative to levels in mock transfected cells, Mean±SEM, n = 3, WT vs. R425, p<0.01), and model simulation (L) (Mean±SEM, n = 3, wt vs. R425, p<0.005). M, N. Mutation of TILRR residue R425 blocks anti-apoptotic responses, determined by TUNEL staining in in vitro experiments, while the D448 substitution has no impact (M) (Mean ±SEM, n = 3, * p<0.001.). Model simulations show that TILRR-induced reductions in pro-apoptotic Caspase-3, is blocked by the R425 mutation but unaffected by substitution at D448 (N) (Mean±SEM, n = 3, wt vs. R425, p<0.01). Graphs in A, C, D, G, I, K, M are reproduced from Zhang, et al. [13,14], and used for validation of the model and for comparison with agent based model output.

History

Usage metrics

    PLOS ONE

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC